| Description | Drug | Neurotransmitter involved |
| Name a melatonin receptor agonist used to treat insomnia; interaction only with a particular SSRI | |
| Name a drug used to treat alcohol addiction that is a glutamate antagonist and increases GABA release | |
| Name an anti-VEGF antibody that can treat wet age-related macular degeneration by blocking blood vessel formation behind the retina | |
| Name an agonist of the 5-HT 1A receptor that reduces some 5-HT neuron firing. Treats generalized anxiety, anxiety with depression | |
| Name a prostaglandin analogue, an agonist of the FP receptor that increases aqueous humour outflow through the uveoscleral route (eyedrops) | |
| Name the classic drug for the treatment of bipolar disorder that inhibits the hydrolysis of inositol-1-phosphate | |
| Name a drug that inhibits reuptake of both 5-HT and NE; treats depression, generalized anxiety, panic disorder, social phobia, PTSD | |
| Name a beta 1/beta 2 receptor antagonist that treats glaucoma by reducing aqueous humour production (eyedrops) | |
| Name the benzodiazepine used for insomnia with the shortest 1/2 life - good for people who need to be alert in the morning | |
| Name an agonist of the benzodiazepine site on the GABA A receptor that ameliorates some of the sequelae of alcohol withdrawal | |
| Name a drug typically considered an anticonvulsant that is also indicated for treatment of bipolar disorder | |
| Name a D2-like receptor, 5-HT2 receptor antagonist used to treat the + and - symptoms of schizophrenia | |
| Name a 5-HT transport inhibitor with alpha 2 agonist and H1 antagonist activity that treats depression and insomnia | |
| Name a long-acting muscarinic receptor that produces long-lasting mydriasis and cycloplegia for a prolonged eye exam | |